S'abonner

Differences in disease presentation between men and women with sarcoidosis: A cohort study - 25/01/22

Doi : 10.1016/j.rmed.2021.106688 
Amanda Lundkvist a, Susanna Kullberg b, c, Elizabeth V. Arkema d, Kerstin Cedelund e, Anders Eklund c, Johan Grunewald b, c, Pernilla Darlington a, f,
a Department of Internal Medicine, Södersjukhuset, Stockholm, Sweden 
b Department of Respiratory Medicine, Theme Inflammation and Ageing, Karolinska University Hospital, Stockholm, Sweden 
c Respiratory Medicine Division, Department of Medicine, Center for Molecular Medicine (CMM), Karolinska Institutet, Stockholm, Sweden 
d Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden 
e Department of Clinical Science, Intervention and Technology, Division of Medical Imaging and Technology at Karolinska Institutet, Stockholm, Sweden 
f Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden 

Corresponding author. Department of Internal Medicine, Södersjukhuset, Stockholm, Sweden.Department of Internal MedicineSödersjukhusetStockholmSweden

Abstract

Background

Sarcoidosis is an elusive disease due to its heterogeneity. It is well recognized that the clinical picture is dependent on ethnicity, organ involvement and age. However, data on the role of sex is inconsistent. We aimed to study the gender-related differences in disease presentation in Swedish patients with sarcoidosis.

Subjects and methods

Clinical data was collected between 1996 and 2020, yielding a register with 1429 cases with sarcoidosis in a pulmonary clinic. The diagnosis was met according to WASOG criteria. Data on age, radiologic stage at the time of disease onset, and potential extra-pulmonary manifestations, was retrieved. Differences between men and women were analyzed with Fisher's Exact Test and t-test where appropriate.

Results

In the register there were 61% men and they were approximately three years younger than the women at the time of diagnosis. Men presented with a more advanced radiographic stage on chest imaging compared to women, radiographic stage II (46% vs 36%, p < 0.001), while women compared to men more often had stage 0-I disease on pulmonary x-rays (6% vs 2%, p < 0.001 for stage 0 and 46% vs 38%, p < 0.01 for stage I). Women had more cutaneous involvement (13% vs 8%, p < 0.01) and more often involvement of salivary glands (3% vs 1%, p < 0.05).

Conclusions

In this cohort with sarcoidosis patients, there was a predominance of men. They presented with more severe disease at a younger age, while women more often were found to have involvement of the skin and salivary glands.

Le texte complet de cet article est disponible en PDF.

Highlights

Among sarcoidosis cases men were overrepresented and younger at disease onset.
Men more often had radiographic stage II while stage 0-I were more common in women.
Women more often had involvement of the skin and salivary glands.

Le texte complet de cet article est disponible en PDF.

Résumé

Keypoints: We aimed to study differences between men and women with sarcoidosis. We found that men were overrepresented, in general younger at disease onset and had a more advanced radiographic stage on chest imaging compared to women.

Le texte complet de cet article est disponible en PDF.

Keywords : Gender differences, Prognosis, Sarcoidosis


Plan


© 2021  The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 191

Article 106688- janvier 2022 Retour au numéro
Article précédent Article précédent
  • Differential serum lipid distribution in IPAH and CHD-PAH patients
  • Jingyuan Chen, Anandharajan Rathinasabapathy, Jun Luo, Xiaojie Yang, Peng Luo, Yusi Chen, Zilu Li, Jiang Li
| Article suivant Article suivant
  • Utility of electrophysiologic testing for sudden death risk stratification in cardiac sarcoidosis patients with mildly impaired left ventricular function
  • Pranai Tandon, Tayseer Mosleh, Ali Mustafa, Hope Miodownik, Marc Miller, Adam S. Morgenthau

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.